Article - 04/02/2013 SYGNIS Pharma - the "new" one: development and commercialisation of molecular diagnostics products Heidelberg-based SYGNIS Pharma AG is to discontinue its therapeutic R&D projects targeting human nervous system diseases and will in future focus on the research and development of novel molecular biology technologies, including DNA amplification and sequencing as well as drug screening.https://www.gesundheitsindustrie-bw.de/en/article/news/sygnis-pharma-the-new-one-development-and-commercialisation-of-molecular-diagnostics-products
Funding 2022 Research Grants – AI for predictive diagnostics & therapeutic target discovery Funding programme, Funded by: Merck KGaA, Submission deadline: 31/08/2022 https://www.gesundheitsindustrie-bw.de/en/database/funding/2022-research-grants-ai-predictive-diagnostics-therapeutic-target-discovery
Article - 11/08/2014 dsl-Labor: developing PCR tests for medical diagnostics PCR has become a common application in medical diagnostics, in areas ranging from the detection of microbes to genetic testing. The demand for new tests is huge, given that there is a seemingly endless list of applications for which PCR can be used. dsl-Labor für Molekulargenetische Diagnostik specialises in the development of PCR tests and also gives advice and training to medical laboratory personnel. Veterinarians are among the company’s major…https://www.gesundheitsindustrie-bw.de/en/article/news/dsl-labor-developing-pcr-tests-for-medical-diagnostics
Microfluidic systems - 18/11/2021 Dermagnostix develops molecular diagnostic tests for skin diseases Dermagnostix GmbH has developed a rapid test to differentiate between psoriasis and eczema. This test is currently undergoing preclinical testing, with market launch planned for 2023. The start-up is already working on two other dermatological tests. Centrifugal microfluidics is the name of the technology on which the tests are based.https://www.gesundheitsindustrie-bw.de/en/article/news/dermagnostix-develops-molecular-diagnostic-tests-skin-diseases
Article - 30/08/2010 A centre focusing on hepatocellular carcinoma research Under its director, Prof. Dr. Peter Schirmacher, the Institute of Pathology at the University of Heidelberg has become a major liver cancer research centre, with a particular focus on hepatocellular carcinoma. The institute is looking for new diagnostic markers and new molecular targets for drugs that have the potential to be used for specifically treating this cancer. https://www.gesundheitsindustrie-bw.de/en/article/news/a-centre-focusing-on-hepatocellular-carcinoma-research
Press release - 27/04/2020 EIT Health pledges €6m funding to accelerate COVID-19 solutions EIT Health has announced over €6m of funding in the fight against COVID-19. The funding will be dedicated to 14 specially selected health innovation projects across Europe which will focus on immediate and impactful solutions that can be found to arm health services with better tools in navigating the pandemic.https://www.gesundheitsindustrie-bw.de/en/article/press-release/eit-health-pledges-eur6m-funding-accelerate-covid-19-solutions
Press release - 22/11/2012 CeGaT and Genomatix are finalists of Boston Children’s Hospital’s CLARITY challenge CeGaT (Center for Genomics and Transcriptomics) GmbH, the Department of Prostate Cancer Research, Institute of Pathology, University Hospital Bonn and Genomatix Software GmbH were announced as finalist (Top 3) of the CLARITY challenge, organized by Boston Children’s Hospital.https://www.gesundheitsindustrie-bw.de/en/article/press-release/cegat-and-genomatix-are-finalists-of-boston-children-s-hospital-s-clarity-challenge
Press release - 18/01/2010 Measurement instead of culture – rapid detection of Legionella There has been an unusually high frequency of Legionella infections in the city of Ulm in the period since mid-December 2009. The search for the source of the infection is well underway, although the use of traditional detection methods make it a time-consuming process. New screening methods developed by the Fraunhofer IPM could considerably reduce the time required to detect the source of infection.https://www.gesundheitsindustrie-bw.de/en/article/press-release/measurement-instead-of-culture-rapid-detection-of-legionella
Article - 29/07/2011 Labor Dr. Merk und Kollegen - Viruses under control It is difficult to imagine how Ochsenhausen-based Labor Dr. Merk und Kollegen (LMK) would be able to develop, produce and test medical products for bacterial and viral contaminations without using cell cultures. The medium-sized company also produces viruses for testing and has stored more than 80 different viruses – enveloped and non-enveloped ones, animal and human pathogens – at -80˚C.https://www.gesundheitsindustrie-bw.de/en/article/news/labor-dr-merk-und-kollegen-viruses-under-control
Press release - 28/05/2009 CONCERT Medical Optics wins special CyberOne prize The company CONCERT Medical Optics was selected from more than 70 participants from all over Germany to receive a special CyberOne prize for the most innovative start-up concept namely a medical instrument called EndoTherapeuthoSkop. This instrument combines different technologies enabling the simultaneous detection and treatment of tumours meaning that patients only have to undergo one rather than several interventions.https://www.gesundheitsindustrie-bw.de/en/article/press-release/concert-medical-optics-wins-special-cyberone-prize
Article - 12/08/2013 Sensovation AG: a special camera for rapid allergy diagnosis Between 20 and 30 million Germans suffer from allergies to house dust mites, pollen and many other allergens¹. The diagnosis of allergies is usually a rather time-consuming process as more than 20,000 potential allergens need to be tested in order to identify the allergen that causes a patient’s particular symptoms². Sensovation AG has developed a technology that allows the parallel analysis of 20 allergens and which has the potential to simplify…https://www.gesundheitsindustrie-bw.de/en/article/news/sensovation-ag-a-special-camera-for-rapid-allergy-diagnosis
Press release - 19/12/2011 cetics healthcare - Metabolomic snapshot – one drop blood is enough Newly founded Esslingen-based cetics healthcare technologies is developing a new platform that combines innovative analysis technologies for medical diagnostics. By linking biological testing methods with spectroscopic detection technology and automation, information on all key blood values and existing medical conditions can be delivered in just one single measurement.https://www.gesundheitsindustrie-bw.de/en/article/press-release/cetics-healthcare-metabolomic-snapshot-one-drop-blood-is-enough
Press release - 06/07/2012 Medicyte is receiving 4.2 Mio Euros from the European Union Seventh Framework Programm Medicyte, The Electrospinning Company and the Universities of Manchester and Pisa launch a European wide unique project with the aim to design a biomimetic bioartificial liver (Re-Liver). The company GABO:mi ensures professional project management. Research is receiving 4.2 Mio Euros from the European Union Seventh Framework Programme.https://www.gesundheitsindustrie-bw.de/en/article/press-release/medicyte-is-receiving-4-2-mio-euros-from-the-european-union-seventh-framework-programm
Article - 10/05/2008 Wilhelm Conrad Röntgen Prize 2008 Prof. Dr. Martin Bendszus was awarded the Wilhelm Conrad Röntgen Prize 2008. He received the prize together with 10000 euros for his work dealing with in vivo diagnostics of the peripheral nervous system using magnetic resonance imaging.https://www.gesundheitsindustrie-bw.de/en/article/news/wilhelm-conrad-roentgen-prize-2008
Article - 12/08/2009 More effective extraction of small RNAs Small RNAs are gaining in importance in research as well as in the biotechnology and pharmaceutical industries. However the potential of these molecules can only be exploited fully if very pure RNAs can be extracted from the cells in sufficiently high quantities. Currently used methods are expensive and only designed for large cell quantities. In addition the operation of the extraction systems is very complicated. A new biochip developed by Dr.…https://www.gesundheitsindustrie-bw.de/en/article/news/more-effective-extraction-of-small-rnas
Diagnostics - 29/01/2018 New test for extended blood fat analysis Cholesterol is seen as the cause of atherosclerosis, a disease that can lead to heart attacks and strokes. However, it now seems that the way cholesterol is packaged may be even more important than high blood cholesterol levels. Nuclear magnetic resonance (NMR) spectroscopy now allows the high-throughput analysis of such lipid packages. https://www.gesundheitsindustrie-bw.de/en/article/news/new-test-for-extended-blood-fat-analysis
Press release - 29/03/2012 GATC Biotech’s NightXpress sequencing service goes Europe-wide GATC Biotech, Europe’s leading sequencing provider, now offers its overnight sequencing service NightXpress Europe wide. This unique overnight service has been made possible by the recently opened European Custom Sequencing Centre in Cologne. In Constance, the company’s headquarters, GATC Biotech is building up the European Genome and Diagnostics Centre.https://www.gesundheitsindustrie-bw.de/en/article/press-release/gatc-biotech-s-nightxpress-sequencing-service-goes-europe-wide
Medical technology - 14/03/2016 The operating room of the future: minimally invasive and future-oriented intervention techniques Being able to diagnose and treat tumour patients in just a few hours is just one of the many promising goals of the Fraunhofer Project Group for Automation in Medicine and Biotechnology (PAMB). The overall goal of the Intervention and Therapy research group is to take innovative technologies for diagnostic and therapeutic interventions from laboratory development to prototype production for use in clinical trials.https://www.gesundheitsindustrie-bw.de/en/article/news/the-operating-room-of-the-future-minimally-invasive-and-future-oriented-intervention-techniques
Article - 03/09/2009 Company establishment with combined forces The company DSL a specialist in molecular diagnostics is currently being established in the city of Eriskirch close to Friedrichshafen Germany. The future managing directors Dr. Sabine Lautenschläger and Dr. Daniel Schaarschmidt are being supported by the BioLAGO network and the pharmaceutical company Nycomed.https://www.gesundheitsindustrie-bw.de/en/article/news/company-establishment-with-combined-forces
Article - 12/08/2013 A complete exome sequence in one week The exome is the part of the genome that is formed by exons i.e. the DNA regions that code for proteins and other functional products. Though comprising only about 1 of the total genome the majority of disease-causing mutations occur in the exome. Selectively sequencing the coding regions of the genome is quicker than whole-genome sequencing. Therefore exome sequencing plays an important role in the diagnosis of genetic diseases and cancer.…https://www.gesundheitsindustrie-bw.de/en/article/news/a-complete-exome-sequence-in-one-week
Press release - 03/12/2018 SpinDiag closes second financing round of EUR 3.0 million (USD 3.4 million) to complete product development of its point-of-care screening system for antibiotic-resistant bacteria One year after its seed financing, SpinDiag GmbH closes a second financing round of EUR 3 million (USD 3.4 million) as planned. The financing will enable SpinDiag to complete the product development of its first product for screening for antibiotic-resistant bacteria and to start clinical trials. This will pave the way for regulatory approval in the EU.https://www.gesundheitsindustrie-bw.de/en/article/press-release/spindiag-closes-second-financing-round-of-eur-30-million-usd-34-million-to-complete-product-development-of-its-point-of-care-scr
Press release - 28/07/2009 Fostering enthusiasm for successful entrepreneurship BioRegio STERN Management GmbH has honoured the winning projects in the regional “Science2Start” competition. A panel of experts awarded a total of 2,250 euros for the most innovative ideas with marketing potential. The winners celebrated their success with approx. 240 visitors of the annual summer event jointly organised by BioRegio STERN Management GmbH, the Society for the Promotion of Biotechnology Stuttgart/Tübingen/Neckar-Alb e.V. and PUSH!…https://www.gesundheitsindustrie-bw.de/en/article/press-release/fostering-enthusiasm-for-successful-entrepreneurship
Press release - 17/12/2012 Curetis AG initiates clinical trial in the U.S. towards FDA clearance Curetis AG announced the start of a clinical trial of its Unyvero™ System and the corresponding LRT (lower respiratory tract) application in the U.S. The company expects enrollment completion within the next 12-15 months, followed by a 510(k) submission to the FDA in 2014. The prospective, multicenter trial will include samples collected from more than 2,000 hospitalized patients suspected to have a lower respiratory tract infection and several…https://www.gesundheitsindustrie-bw.de/en/article/press-release/curetis-ag-initiates-clinical-trial-in-the-u-s-towards-fda-clearance
Press release - 20/10/2008 Ultra fast magnetic resonance imaging The European Research Council is to fund a project at the University Hospital of Freiburg on the development of ultra fast magnetic resonance imaging for applications in the fields of neurology the neurosciences and oncology.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ultra-fast-magnetic-resonance-imaging
Dossier - 03/07/2008 Molecular imaging - a close look inside the human body Molecular imaging recognises the functional state of cells and molecules. It visualises biological processes on the cellular and molecular level and is thus able to detect pathological alterations a long time before disease symptoms become apparent. Molecular imaging offers new possibilities for improving diagnosis and enabling more targeted therapies than has previously been possible. Many experts regard molecular imaging as a paradigm shift in…https://www.gesundheitsindustrie-bw.de/en/article/dossier/molecular-imaging-a-close-look-inside-the-human-body